MedTrace Logo

Women's Isoflavone Soy Health (WISH) Trial

NCT00118846 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2023-05-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether soy supplementation can reduce hardening of the arteries and cognitive decline in postmenopausal women.

Conditions

Interventions

DIETARY_SUPPLEMENT

25 gm soy protein supplement

25 gm soy protein supplementation administered in equally divided dosage twice daily (12.5 gm)

OTHER

Placebo

Milk protein administered twice daily

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Office of Dietary Supplements (ODS)

    collaborator NIH

  • Office of Research on Women's Health (ORWH)

    collaborator NIH

  • Solae, LLC

    collaborator INDUSTRY

  • University of Southern California

    lead OTHER

Principal Investigators

  • Howard N. Hodis, M.D. · Atherosclerosis Research Unit, University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-12
Primary Completion
2009-03-19
Completion
2009-03-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118846 on ClinicalTrials.gov